Literature DB >> 26034323

Recurrent myocardial infarction secondary to Prinzmetal's variant angina.

Dale Murdoch1, Priyanka Dhillon2, Selvanayagam Niranjan3.   

Abstract

Prinzmetal's variant angina describes chest pain secondary to reversible coronary artery vasospasm in the context of both diseased and non-diseased coronary arteries. Symptoms typically occur when the patient is at rest and are associated with transient ST-segment elevation. Acute episodes respond to glyceryl trinitrate, but myocardial infarction and other potentially fatal complications can occur, and long-term management can be challenging. Although it is not well understood, the underlying mechanism appears to involve a combination of endothelial damage and vasoactive mediators. In this case, a 35-year-old woman with myocardial infarction secondary to coronary artery vasospasm experienced recurrent chest pain. Coronary angiography revealed severe focal stenosis in the mid left anterior descending artery, which completely resolved after administration of intracoronary glyceryl trinitrate. The patient was discharged on nitrates and calcium channel blockers. The patient re-presented with another myocardial infarction, requiring up-titration of medical therapy.

Entities:  

Keywords:  Prinzmetal’s variant angina; coronary artery spasm; myocardial infarction; vasospastic angina

Mesh:

Substances:

Year:  2015        PMID: 26034323      PMCID: PMC4447936          DOI: 10.11622/smedj.2015077

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  15 in total

Review 1.  Coronary artery spasm: a 2009 update.

Authors:  Shlomo Stern; Antoni Bayes de Luna
Journal:  Circulation       Date:  2009-05-12       Impact factor: 29.690

Review 2.  Prinzmetal's variant angina.

Authors:  S Mayer; L D Hillis
Journal:  Clin Cardiol       Date:  1998-04       Impact factor: 2.882

3.  Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes.

Authors:  J T Willerson; L D Hillis; M Winniford; L M Buja
Journal:  J Am Coll Cardiol       Date:  1986-07       Impact factor: 24.094

4.  Endothelial nitric oxide synthase T-786C mutation, a reversible etiology of Prinzmetal's angina pectoris.

Authors:  Charles J Glueck; Jitender Munjal; Ayub Khan; Muhammad Umar; Ping Wang
Journal:  Am J Cardiol       Date:  2010-03-15       Impact factor: 2.778

5.  Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786-->C and missense Glu298Asp variants.

Authors:  M Yoshimura; H Yasue; M Nakayama; Y Shimasaki; H Ogawa; K Kugiyama; Y Saito; Y Miyamoto; Y Ogawa; T Kaneshige; H Hiramatsu; T Yoshioka; S Kamitani; H Teraoka; K Nakao
Journal:  J Investig Med       Date:  2000-09       Impact factor: 2.895

6.  Coronary vasospasm as a possible cause of elevated cardiac troponin I in patients with acute coronary syndrome and insignificant coronary artery disease.

Authors:  Chao-Hung Wang; Li-Tang Kuo; Ming-Jui Hung; Wen-Jin Cherng
Journal:  Am Heart J       Date:  2002-08       Impact factor: 4.749

7.  Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study.

Authors:  Peter Ong; Anastasios Athanasiadis; Stephan Hill; Holger Vogelsberg; Matthias Voehringer; Udo Sechtem
Journal:  J Am Coll Cardiol       Date:  2008-08-12       Impact factor: 24.094

8.  Angina pectoris. I. A variant form of angina pectoris; preliminary report.

Authors:  M PRINZMETAL; R KENNAMER; R MERLISS; T WADA; N BOR
Journal:  Am J Med       Date:  1959-09       Impact factor: 4.965

9.  The sensitivity of intracoronary injection of acetylcholine in inducing coronary spasm differs in patients with stable and unstable angina.

Authors:  K Miwa; M Fujita; M Ejiri; S Sasayama
Journal:  Int J Cardiol       Date:  1992-09       Impact factor: 4.164

10.  Variant angina complicated by polymorphic ventricular tachycardia.

Authors:  Ashley Chin; Michelle Casey
Journal:  Int J Cardiol       Date:  2009-02-07       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.